Caffeine Blues_ Wake Up to the Hidden Dangers of America's #1 Drug ( PDFDrive )
Page 38
55
E. Joosten, E. Lesaffre, R. Riezler et al., “Is Metabolic Evidence for Vitamin B-12 and Folate Deficiency More Frequent in Elderly Patients with Alzheimer’s
Disease?” Journal of Gerontology, March 1997;52(2):M76–79. (back to text) 56
K. Robinson, E. L. Mayer, D. P. Miller et al., “Hyperhomocysteinemia and Low Pyridoxal Phosphate: Common and Independent Reversible Risk Factors for Coronary Artery Disease,” Circulation, November 15, 1995;92(10):2825–30.
(back to text)
57
P Modica, “The Coffee Craze and Your Health,” Medical Tribune, June 25, 1997. (back to text)
58
K. Robinson, “Hyperhomocysteinemia,” 2825–30. (back to text) 59
L. J. Freeman, P. G. Nixon, P. Sallabank et al., “Psychological Stress and Silent Myocardial Ischemia,” American Heart Journal, September 1987;114(3):477–82. (back to text)
60
M. K. Pope and T. W. Smith, “Cortisol Excretion in High and Low Cynically Hostile Men,” Psychosomatic Medicine, July-August 1991;53(4):386–92. (back to text)
61
M. Abdulla, A. Behbehani, and H. Dashti, “Dietary Intake and Bioavailability of Trace Elements,” Biological Trace Element Research, July-September 1989;21:173–78. (back to text)
62
R. B. Costello, P. B. Moser-Veillon, and R. DiBianco, “Magnesium Supplementation in Patients with Congestive Heart Failure,” Journal of the American College of Nutrition, February 1997;16(1):22–31. (back to text) 63
L. Massey and T Berg, “The Effect of Dietary Caffeine on Urinary Excretion of Calcium, Magnesium, Phosphorus, Sodium, Potassium, Chloride and Zinc in Healthy Males,” Nutrition Research, 1985;5:1281–84. (back to text) 64
E. A. Bergman, L. K. Massey, K. J. Wise et al., “Effects of Dietary Caffeine on Renal Handling of Minerals in Adult Women,” Life Sciences, 1990;47(6):557–64. (back to text)
65
B. M. Altura, A. Gebrewold, B. T. Altura et al., “Magnesium Depletion Impairs Myocardial Carbohydrate and Lipid Metabolism and Cardiac Bioenergetics and Raises Myocardial Calcium Content In-Vivo: Relationship to Etiology of Cardiac Diseases,” Biochemical and Molecular Biology International, December 1996;40(6): 1183–90. (back to text) 66
B. I. Hustler, J. Singh, J. J. Waring et al., “Dietary and Physiological Studies Involving Magnesium Homeostasis in the Heart,” Annals of the New York
Academy of Sciences, September 30, 1996;793:473–78. (back to text) 67
R. B. Singh, U. C. Gupta, N. Mittal et al., “Epidemiologic Study of Trace Elements and Magnesium on Risk of Coronary Artery Disease in Rural and Urban Indian Populations,” Journal of the American College of Nutrition, February 1997;16(1):62–67. (back to text)
68
S. Douban, M. A. Brodsky, D. D. Whang et al., “Significance of Magnesium in Congestive Heart Failure,” American Heart Journal, September 1996;132(3):664–71. (back to text)
69
H. G. Henrotte, P. F. Plouin, C. Levy-Leboyer et al., “Blood and Urinary Magnesium, Zinc, Calcium, Free Fatty Acids, and Catecholamines in Type A and Type B Subjects,” Journal of the American College of Nutrition, 1985;4(2):165–72. (back to text)
70
M. Zehender, T. Meinertz, T. Faber et al., “Antiarrhythmic Effects of Increasing the Daily Intake of Magnesium and Potassium in Patients with Frequent Ventricular Arrhythmias: Magnesium in Cardiac Arrhythmias (MAGICA) Investigators,” Journal of the American College of Cardiology, April 1997;29(5):1028–34. (back to text)
71
L. Rosenberg, J. R. Palmer, J. P. Kelly et al., “Coffee Drinking and Nonfatal Myocardial Infarction in Men under 55 Years of Age,” American Journal of Epidemiology, 1988;128(3):570–78. (back to text)
72
A. Gramenzi, A. Gentile, M. Fasoli et al., “Association between Certain Foods and Risk of Acute Myocardial Infarction in Women,” British Medical Journal, 1990;300(6727):771–73. (back to text)
73
L. Rosenberg, D. Slone, S. Shapiro et al., “Coffeedrinking and Myocardial Infarction in Young Women,” American Journal of Epidemiology, 1980; 111:675. (back to text)
74
J. E. James, “Is Habitual Caffeine Use a Preventable Cardiovascular Risk Factot?” Lancet, January 25, 1997:349(9047) :279–81. (back to text) 75
C. La Vecchia, A. Gentile, E. Negri et al., “Coffee Consumption and Myocardial Infarction in Women,” American Journal of Epidemiology, September 1989; 130(3):481–85. (back to text)
76
G. A. Pincomb, W. R. Lovallo, R. B. Passey et al., “Effect of Behavior State on Caffeine’s Ability to Alter Blood Pressure,” American Journal of Cardiology,
April 1, 1988:61(10)798–802. (back to text)
77
A. Wennmalm and M. Wennmalm, “Coffee, Catecholamines and Cardiac Arrhythmia,” Clinical Physiology, June 1989;9(3):201–06. (back to text) 78
D. Ornish, S. E. Brown, L. W. Scherwitz et al., “Can Lifestyle Changes Reverse Coronary Heart Disease? The Lifestyle Heart Trial,” Lancet, July 21, 1990; 336(8708):129–33. (back to text)
79
J. B. Ubbink, W. J. H. Vermaals, A. vander Merwe et al., “Vitamin B-12, Vitamin B-6, and Folate Nutritional Status in Men with
Hyperhomocysteinemia,” American Journal of Clinical Nutrition, 1993;57:47–53. (back to text)
80
I. M. Graham, L. Daly, H. Refsum et al., “Plasma Homocysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project,” Journal of the American Medical Association, 1997;277:1775–81. (back to text) 81
E. B. Rimm, M. J. Stampfer, A. Ascherio et al., “Vitamin E Consumption and the Risk of Coronary Heart Disease in Men,” New England Journal of Medicine, 1993;328:1450–56. (back to text)
82
M. J. Stampfer, C. H. Hennekens, J. E. Manson et al., “Vitamin E and the Risk of Coronary Disease in Women,” New England Journal of Medicine, 1993;328:1444–49. (back to text)
83
New England Journal of Medicine, April 20, 1997. (back to text) 84
Reversing Heart Disease through Diet, Exercise, and Stress Management: An Interview with Dean Ornish,” Journal of the American Dietetic Association, February 1991;91(2):162–65. (back to text)
85
P. Hill, “It Is Not What You Eat, but How You Eat It: Digestion, Life-sryle, Nutrition,” Nutrition, November 1991;7(6):385–95. (back to text) 86
B. B. Fredholm, “Gastrointestinal and Metabolic Effects of Methylxanthines,”
Progress in Clinical and Biological Research, 1984:158:331–54. (back to text) 87
M. W. Groer, S. Humenick, and P. D. Hill, “Characterizations and Psychoneuroim-munologic Implications of Secretory Immunoglobulin A and Cortisol in Preterm and Term Breast Milk,” Journal of ‘Perinatal and Neonatal Nursing, March 1994;7(4):42–51. (back to text)
88
P. Brauchli, “Comparative Study of the Psychophysiologic Relaxation Effects
of an Optic-acoustic Mind Machine with Relaxation Music,” Zeitschrift fur Experimented und Angewandte Psychologic 1993:40(2):179–93. (back to text) 89
M. U. Khanna and P Abraham, “Determinants of Acid Secretion,” Journal of the Association of Physicians in India, September 1990;38 supplement 1:727–30. (back to text)
90
S. Cohen, “Pathogenesis of Coffee-induced Gastrointestinal Symptoms,” New England Journal of Medicine, July 17, 1980;303(3):122–24. (back to text) 91
E. Turchetto, “Effects of Coffee on Digestion,” Minerva Medica, September 5, 1972;63(61):3314–18. (back to text)
92
H. Glatzel and K. Hackenberg, “Effects of Caffeine Containing and Decaffeinated Coffee on the Digestive Functions: X-ray Studies of the Secretion and Peristalsis of Stomach, Intestines and Gallbladder,” Medizinische Klinik, April 21, 1967; 62(16):625–28. (back to text)
93
C. A. Loehry, J. Kingham, and J. Baker, “Small Intestinal Permeability in Animal
s and Man,” Gut, September 1973;14(9):683–88. (back to text) 94
K. R. Gardiner, N. H. Anderson, B. J. Rowlands et al., “Colitis and Colonic Mucosal Barrier Dysfunction,” Gut, October 1995;37(4):530–35. (back to text) 95
P. Forget, F. Sodoyez-Goffaux, A. Zappitelli et al., “Permeability of the Small Intestine to [51Cr]EDTA in Children with Acute Gastroenteritis or Eczema,”
Journal of Pediatric Gastroenterology and Nutrition, June 1985;4(3):393–96.
(back to text)
96
B. O. Eggum, B. Pederson, and I. Jacobsen, “The Influence of Dietary Tea, Coffee and Cocoa on Protein and Energy Utilization of Soya-bean Meal and Barley in Rats,” British Journal of Nutrition, September 1983;50(2):197–205.
(back to text)
97
R. R. Babb, “Coffee, Sugars, and Chronic Diarrhea: Why a Dietary History Is Important,” Postgraduate Medicine, June 1984;75(8):82. (back to text) 98
E. Krag, “Irritable Bowel Syndrome: Current Concepts and Future Trends,”
Scandinavian Journal of Gastroenterology, supplement 1985:109:107–15. (back to text)
99
R. S. Sandier, M. C. Jordan, and B. J. Shekon, “Demographic and Dietary Determinants of Constipation in the U.S. Population,” American Journal of Public Health, February 1990;80(2):185–89. (back to text)
100
S. R. Brown, P. A. Cann, and N. W. Read, “Effect of Coffee on Distal Colon Function,” Gut, April 1990;31(4):450–53. (back to text) 101
A. Wald, C. Back, and T. M. Bayless, “Effect of Caffeine on the Human Small Intestine,” Gastroenterology, 1976;71:738. (back to text) 102
F. B. Thomas, J. T. Steinbaugh, J. J. Fromkes et al., “Inhibitory Effect of Coffee on Lower Esophageal Sphincter Pressure,” Gastroenterology, December 1980; 79(6):1262–66. (back to text)
103
B. Wendl, A. Pfeiffer, C. Pehl et al., “Effect of Decaffeination of Coffee or Tea on Gastro-oesophageal Reflux,” Alimentary Pharmacology and Therapeutics, June 1994;8(3):283–87. (back to text)
104
S. Cohen, “Pathogenesis of Coffee-induced Gastrointestinal Symptoms,”
New England Journal of Medicine, July 17, 1980;303(3):122–24. (back to text) 105
S. R. Brazer, J. E. Onken, C. B. Dalton et al., “Effect of Different Coffees on Esophageal Acid Contact Time and Symptoms in Coffee-sensitive Subjects,”
Physiology and Behavior, March 1995;57(3):563–67. (back to text) 106
American Family Physician, 1992;45(3):995. (back to text) 107
K. Taniyama, “GABAergic Neurons in the Mammalian Intestine,” Nippon Yakurigaku Zasshi, May 1985;85(5):305–13. (back to text) 108
E. Sundlet, G. Bottcher, E. Ekblad et al., “The Neuroendocrine System of the Gut,” Acta Oncologia 1989;28(3):303–14. (back to text)
109
G. Gentilini, S. Franchi-Micheli, D. Pantalone et al., “GABAB Receptormediated Mechanisms in Human Intestine In Vitro,” European Journal of Pharmacology, June 24, 1992;217(1):9–14. (back to text) 110
D. J. Roca, G. D. Schiller, and D. H. Farb, “Chronic Caffeine or Theophylline Exposure Reduces Gamma-aminobutyric Acid/Benzodiazepine Receptor Site Interactions,” Molecular Pharmacology, May 1988;33(5):481–85.
(back to text)
111
P. Demol, H. J. Ruoff, and T. R. Weihrauch, “Rational Pharmacotherapy of Gastrointestinal Motility Disorders,” European Journal of Pediatrics, April 1989;148(6):489–95. (back to text)
112
S. Levenstein, C. Prantera, V. Varvo et al., “Psychological Stress and Disease Activity in Ulcerative Colitis: A Multidimensional Cross-Sectional Study,”
American Journal of Gastroenterology, August l994;89(8):1219–25. (back to text)
113
M. Tatsuta, H. Iishi, M. Baba et al., “Attenuation by the GABA Receptor Agonist Badofen of Experimental Carcinogenesis in Rat Colon by Azoxymethane,” Oncology, 1992;49(3):241–45. (back to text) 114
M. E. Tucker, “Despite H. pylori, Stress Still a Factor in Ulcers,” Family Practice News, 1994;24(12):17. (back to text)
115
R. B. Marotta and M. H. Floch, “Diet and Nutrition in Ulcer Disease,”
Medical Clinics of North America, July 1991; 75(4):967–79. (back to text) 116
R. B. Johnson, D. M. McCance, and W. M. Lukash, “Coffee—Treat or Trick?” American Family Physician, 1975;11:101–04. (back to text) 117
S. Hayashi, T. Sugiyama, K. Hisano et al., “Quantitative Detection of Secretory Imrhunoglobulin A to Helicobacterpylori in Gastric Juice: Antibody Capture Enzyme-linked Immunosorbent Assay,” Journal of Clinical and Laboratory Analysis, 1996;10(2):74–77. (back to text)
118
R. F. Anda et al., “Self-perceived Stress and the Risk of Peptic Ulcer Disease: A Longitudinal Study of U.S. Adults,” Archives of Internal Medicine, April 1992;152:829–33. (back to text)
119
S. Levenstein, C. Prantera, M. L. Scribano et al., “Psychologic Predictors of Duodenal Ulcer Healing,” Journal of Clinical Gastroenterobgy, March 1996;22(2):84–89. (back to text)
120
A. Ramirez-Ramos, R. H. Gilman, R. Leon-Barua et al., “Rapid Recurrence of Helicobacter pylori Infection in Peruvian Patients after Successful Eradication,” Clinical Infectious Diseases, November 1997;25 (5): 1027–31.
(back to text)
121
O. Pieramico, M. V. Zanetti, M. Innerhofer et al., “Omeprazole-based Dual and Triple Therapy for the Treatment of Helicobacter pylori Infection in Peptic Ulcer Disease: A Randomized Trial,” Helicobacter, June 1997;2(2):92–97.
(back to text)
122
J. M. Ritchie, “Caffeine” in Goodman and Gillman (eds.), The Pharmacological Basis of Therapeutics, (4th ed.), 1970:359. (back to text) 123
R. C. Pearson and R. F. McCloy, “Preference for Hot Drinks Is Associated with Peptic Disease,” Gut, September 1989;30(9):1201–05. (back to text)
124
G. Friedman, “Nutritional Therapy of Irritable Bowel Syndrome,”
Gastroenterology Clinics of North America, September 1989;18(3):513–24.
(back to text)
125
G. Heuther, “Melatonin Synthesis in the Gastrointestinal Tract and the Impact of Nutritional Factors on Circulating Melatonin,” Annals of the New York Academy of Sciences, 1994;719:146–58. (back to text)
126
P. C. Konturek, S. J. Konturek, T. Brzozowski et al., “Gastroprotective Activity of Melatonin and Its Precursor, L-tryptophan, Against Stress-induced and Ischaemia-induced Lesions Is Mediated by Scavenge of Oxygen Radicals,”
Scandinavian Journal of Gastroenterology, May 1997;32(5)433–38. (back to text)
127
T. Brzozowski, P. C. Konturek, S. J. Konturek et al., “The Role of Melatonin and L-tryptophan in Prevention of Acute Gastric Lesions Induced by Stress, Ethanol, Ischemia, and Aspirin,” Journal of Pineal Research, September 1997;23(2):79–89. (back to text)
128
P. Modica, “The Coffee Craze and Your Health,” Medical Tribune News Service, June 25, 1997. (back to text)
129
P. A. Nathan, R. C. Keniston, R. S. Lockwood et al., “Tobacco, Caffeine, Alcohol, and Carpal Tunnel Syndrome in American Industry: A Cross-sectional Study of 1,464 Workers,” Journal of Occupational and Environmental Medicine, March 1996;38(3):290–98. (back to text)
130
J. M. McPartland and J. A. Mitchell, “Caffeine and Chronic Back Pain,”
Archives of Physical Medicine and Rehabilitation, January 1997;78(1):61–63.
(back to text)
131
S. Seltzer, “Foods, and Food and Drug Combinations, Responsible for Head and Neck Pain,” Cephalalgia, June 1982;2(2):111–24. (back to text) 132
J. P. Savineau and J. Mironneau, “Caffeine Acting on Pregnant Rat Myometrium: Analysis of Its Relaxant Action and Its Failure to Release Ca2+
from Intracellular Stores,�
�� British Journal of Pharmacology, February 1990;99(2):261–66. (back to text)
133
R. C. Small, J. P. Boyle, J. Cortijo et al., “The Relaxant and Spasmogenic Effects of Some Xanthine Derivatives Acting on Guinea-pig Isolated Trachealis Muscle,” British Journal of Pharmacology, August 1988;94(4):1091–1100.
(back to text)
134
S. V. Hildebrand, D. Aripin, and G. Cardinet 3d, “Contracture Test and Histologic and Histochemical Analyses of Muscle Biopsy Specimens from Horses with Exertional Rhsbdorayolysis,” Journal of the American Veterinary Medical Association, April 1, 1990;196(7):1077–83. (back to text) 135
S. Orimo, M. Araki, H. Ishii et al., “A Case of ‘Myopathy with Tubular Aggregates’ with Increased Muscle Fibre Sensitivity to Caffeine,” Journal of Neurology, August 1987;234(6):424–26. (back to text)
136
R. Leira and R. Rodriguez, “Diet and Migraine,” Revista de Neurologia, May 1996;24(129):534–38. (back to text)
137
O. G. Cameron, J. G. Modell, and M. Hariharan, “Caffeine and Human Cerebral Blood Flow. A Positron Emission Tomography Study,” Life Sciences, 1990; 47(13):1141–46. (back to text)